HomeClinical TopicsFDA allows marketing of ‘next generation’ gene sequencing devices

FDA allows marketing of ‘next generation’ gene sequencing devices

Author(s):

On Nov. 19, the U.S. Food and Drug Administration (FDA) allowed marketing of four diagnostic devices that can be used for high throughput gene sequencing, often referred to as “next generation sequencing” (NGS). Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content

For Nurse Practitioners

Pregnant woman drinking coffee

Cup of Coffee Can Lessen Gestational Diabetes Risk

Pregnant mothers concerned about being able to safely enjoy their morning cup of coffee should be reassured by a recent University of Pennsylvania study...